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Purpose: Pediatric cataract is the most common form of treatable childhood blindness and is both clinically and genetically
heterogeneous. Autosomal dominant and recessive forms of cataract have been reported to be caused by mutations in 22
different genes so far. Of the cataract mutations reported to date, about half the mutations occur in crystallins, a quarter
of the mutations in connexins, and the remainder is evenly divided between intrinsic membrane proteins, intermediate
filament proteins, and transcription factors. This study is aimed at identification of the spectrum and frequency of crystallin
gene mutations in cataractous patients in an Indian population.
Methods: Genetic analysis was extended to screen the entire coding region of the CRYAA, CRYAB, CRYBA1, CRYBA4,
CRYBB1, CRYBB2, CRYBB3, CRYGC, CRYGD, and CRYGS genes using single stranded conformational polymorphism
(SSCP) analysis as a screening technique followed by direct sequencing of all subjects that displayed an electrophoretic
shift.
Results: This report describes the first simultaneous mutation analysis of 10 crystallin genes in the same population,
represented by 60 south Indian families. The analysis allowed the identification of causative mutations in 10 of the families
(three novel and six reported). This includes six missense mutations (CRYAA-R12C, R21W, R54C, CRYAB- A171T,
CRYGC-R168W, CRYGS- S39C), two nonsense mutations (CRYBB2- Q155X, CRYGD- R140X), and one splice
mutation, which was identified in two families (CRYBA1-IVS3+1G>A).
Conclusions: Crystallin mutations are responsible for 16.6% of the inherited pediatric cataract in this population. As
causative mutations have not been found in many of the families analyzed, this study suggests the presence of further
novel genes or sequence elements involved in the pathogenesis of cataract in these families.
Pediatric cataracts are common and represent one of the
most  treatable  causes  of  lifelong  visual  impairment.  It  is
estimated that globally, 20 million children under the age of
16 suffer from cataract, and among these, 200,000 (15%) are
severely visually impaired or blind [1,2]. While this figure is
relatively low compared to the 17 million (40%) adults who
are blind due to cataract [3], the burden of disability in terms
of “blind-years” is huge due to the child’s life expectancy after
developing  the  visual  disability.  In  addition,  untreated
congenital  cataracts  can  cause  permanent  blindness  by
interfering with the focus of light on the retina, necessary for
formation  of  neural  pathways  necessary  for  vision.  This
presents an enormous problem in developing countries in
terms of human morbidity, economic loss, and social burden.
Pediatric  cataracts  are  both  clinically  and  genetically
heterogeneous. About one-third to one-half of all bilateral
pediatric cataracts have a genetic basis [4-6]. All three forms
of Mendelian inheritance have been observed, and the most
frequently  seen  in  non-consanguineous  populations  is
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autosomal dominant (AD) transmission [7,8]. To date, at least
34  loci  in  the  human  genome  have  been  reported  to  be
associated with various forms of pediatric cataract. Of the
mapped loci, mutations have been identified in 22 specific
genes including encoding crystallins (CRYAA [9], CRYAB
[10], CRYBA1 [11], CRYBA4 [12], CRYBB1 [13], CRYBB2
[14], CRYBB3 [15], CRYGC,CRYGD [16], and CRYGS [17]),
cytoskeletal  proteins  (BFSP1  [18]  and  BFSP2  [19]),
membrane proteins (GJA3 [20] and GJA8 [21], MIP [22] and
LIM2 [23]), transcription factors (HSF4 [24], PITX3 [25], and
MAF [26]), glucosaminyl (N-acetyl) transferase 2 (GCNT2
[27]), chromatin modifying protein-4B (CHMP4B [28]), and
TMEM114 [29]. On the basis of current studies, mutations in
about half of affected families occur in crystallins, a quarter
in  connexins,  and  the  remainder  is  evenly  split  between
membrane  proteins,  intermediate  filament  proteins,  and
transcription factors. However, the relative contribution of
these classes of genes to pediatric cataracts in India is still
unclear.
Crystallins are the major cytoplasmic proteins of the lens
and their stability and appropriate interactions are critical for
lens transparency. Crystallin genes encode more than 95% of
the water soluble structural proteins present in the vertebrate
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1157lens and their encoded proteins account for more than 30% of
its mass. In 1894, Morner first separated bovine lens proteins
into three soluble fractions and one insoluble fraction [30].
The soluble fractions consisted of α-, β-, and  γ-crystallins,
which are found in all vertebrate lenses and are referred to as
“ubiquitous  crystallins.”  In  the  mature  human  lens,  α-
crystallin makes up roughly 40%, β-crystallin 35%, and γ-
crystallin 25% of the total crystallin protein. The β- and γ-
crystallins form a super family as they share a common two
domain structure composed of four extremely stable, torqued
β-pleated  sheets  termed  “Greek  key”  motifs.  At  least  13
functional crystallin genes have been identified in humans,
and of these, 10 major crystallin genes have been associated
with pediatric cataract [12,31].
To clarify the relative contributions of mutations in the
crystallin  genes  to  congenital  cataracts  in  the  Indian
population, a systematic screening of the 10 crystallin genes
associated with cataract was performed in a large panel of
congenital cataract patients.
METHODS
Family ascertainment: Patients with a positive family history
of  childhood  cataract  were  recruited  from  the  Pediatric
Ophthalmology  Clinic,  Aravind  Eye  Hospital  (AEH),
Madurai, India. The family members were interviewed to
obtain a detailed medical, ophthalmic, and family history and
were included in the study based on their availability and
willingness. Patients with a history suggestive of intrauterine
infection such as rubella, complicated cataract, and traumatic
cataract were excluded from the study.
Ophthalmologic examination included the best corrected
visual acuity (Snellen’s), slit lamp biomicroscopy, intraocular
pressure measurement by applanation tonometry, and fundus
examination.  Corneal  diameter  and  axial  length  were
measured  when  indicated.  In  addition,  the  probands  were
examined by a physician to check for the presence of other
systemic abnormalities. Photographs of significant findings
were taken depending upon the cooperation of the patient.
Normal  subjects  were  drawn  from  the  General
Ophthalmology Clinic of the Aravind Eye Hospital (AEH)
matching  the  ethnic  distribution  of  the  pediatric  cataract
patients. Ethics approval for the study was obtained from the
Institutional  Review  Boards  of  the  AEH  and  Combined
Neuroscience IRB at the National Eye Institute, and the study
was performed in accordance to the tenets of Declaration of
Helsinki.  Informed  consent  was  obtained  from  the
participating members in the study. DNA was extracted from
venous blood as previously described [32].
Molecular analysis: One affected representative individual
from each of the identified families was chosen for mutation
analysis. Primers were designed to amplify the entire coding
exons and 10–30 bp of the flanking intronic sequences of the
10 crystallin genes - CRYAA, CRYAB, CRYBA1, CRYBA4,
CRYBB1, CRYBB2, CRYBB3, CRYGC, CRYGD, and CRYGS
(primer  sequences  available  upon  request).  Single  strand
conformational  polymorphism  (SSCP)  analysis  was
employed in the detection of mutations. The amplicons were
denatured at 98 °C for 5 min and electrophoresed at 700–800
V  for  8  −12  h  at  room  temperature  on  6%–12%
polyacrylamide gels. Additives including glycerol (5%–10%)
were used in gels. The gels were silver stained according to
the  modified  protocol  of  Bassam  et  al.  [33].The  samples
whose  electrophoresis  patterns  differed  from  those  of  the
controls  were  sequenced.  The  polymerase  chain  reaction
(PCR)  product  was  purified  using  Ampure  and  CleanSeq
purification kits (Agencourt, Beckman, Beverly, MA) on a
Beckman  NX  MC  automated  workstation  (Beckman).
Sequencing  of  the  DNA  was  performed  using  chain
terminator chemistry with a Big Dye terminator v3.1 Cycle
Sequencing Kit (Applied Biosystems, Foster City, CA) on an
ABI 3130 DNA analysis system.
The DNA sequence was analyzed and compared with the
reference  sequence  using  the  Seqman  program  of  the
DNASTAR analysis package (Lasergene, Madison, WI). If a
nonsynonymous sequence change that results in a change in
the amino acid sequence of the protein was found, available
family members were then analyzed for cosegregation of the
genotype  with  the  phenotype.  In  addition,  100  control
chromosomes  were  analyzed  to  confirm  association  of  a
previously  described  mutation,  and  200  normal  control
chromosomes were analyzed to confirm the association of a
novel  sequence  variation  with  the  disease  phenotype.  If
available, the presence or the absence of a restriction site was
employed to confirm the cosegregation of sequence variation
among the family members and in the control population.
When  no  suitable  restriction  site  was  identified,  direct
sequencing was performed to analyze the cosegregation of the
genotype with the disease phenotype.
Homology modeling: Modeling of the human βγ-crystallins,
γC- and γS-crystallin, was performed by homology modeling
based on correspondent crystal coordinates for murine protein
structures (Brookhaven Protein Database [PDB] files: 2v2u
and 1zw0) as the structural templates [34]. For each model,
primary sequences were aligned by the method of Needleman
and  Wunsch  [35]  and  incorporated  in  the  program,  Look
version  3.5.2  [36,37]  for  three-dimensional  structure
prediction.  Finally,  two  models  of  γC-  and  γS-crystallin
monomers were built by the automatic segment matching
method in the program, Look, followed by 500 cycles of non-
bound energy minimization [38]. These models were used to
predict the effect of mutations in CRYGC and CRYGS. In
addition,  structures  of  two  human  βγ-crystallins,  γD-  and
βB2-crystallin, (PDB files: 1ytq and 1hk0, respectively) were
chosen  to  model  mutations  identified  in  CRYGD  and
CRYBB2. The conformations of the proteins with mutations
Q155X (βB2-crystallin), R168W (γC-crystallin), R140X (γD-
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1159crystallin),  and  S39C  (γS-crystallin)  were  modeled  and
refined by self-consistent ensemble optimization (500 cycles)
[37].
RESULTS AND DISCUSSION
A total of 60 patients below the age of 25 years with a positive
family history of pediatric cataract were registered for the
study. The families were coded as CCW1-CCW60 according
to the order collected. The mode of inheritance was inferred
from  the  pedigree  based  on  the  vertical  or  horizontal
transmission  as  dominant  or  recessive  inheritance,
respectively. About 53% (n=32) had AD inheritance, 30%
(n=18) had autosomal recessive (AR) inheritance, and in 17%
(n=10), the inheritance pattern could not be determined. The
age of onset was recorded as the age at which the disease was
first noticed by the child’s parents or first documented by a
clinician. Depending on the age of onset, the pediatric cataract
was classified as congenital, infantile, or juvenile cataract.
Congenital cataracts present at birth were observed in 56%
(n=33) of the patient families. An additional 8% (n=5) had
Figure 1. Pedigree, electropherogram, and restriction fragment length polymorphism of ADCC families with a mutation in the α-crystallin
gene. In the pedigree, the square symbol represents males while the circle symbol represents females. A circle with a slash denotes a deceased
individual, and a blackened symbol denotes an affected individual. The dot on the upper right corner of the symbol means a sample was
available from that individual, and the arrow denotes the proband. A, B, C show mutation analyses of CRYAA. A: Family CCW46 shows a
heterozygous c.104 C>T resulting in a novel ApaLI restriction site (mutant allele−191 and 63 bp, wild type−254 bp) B: Family CCW36 shows
a c.130 C>T change that results in the loss of the MspI restriction site (mutant allele-254 bp, wild type-116, 90, and 48 bp) C: Family CCW55
shows the gain of a novel HpyCH4V site cosegregating with the affected individual heterozygous for c.230 C>T transition (mutant allele-254,
191, and 63 bp and wild type-254 bp). D: Family CCW22 has a mutation in CRYAB, c.557G>A. This mutation results in the loss of a HpyF10VI
site (mutant allele-258 and 118 bp, wild type-258, 77, and 41 bp). M denotes 100 bp DNA ladder, and C denotes unrelated control.
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1160infantile cataracts that developed within the first three years
of life, and cataracts that developed within the second decade
of  life  and  were  characterized  as  juvenile  cataract  were
observed in 33% (n=20). Finally, 3% of the families (n=2) had
a variable age of onset. Fifteen families also revealed other
associated  ocular  disorders  such  as  microcornea,
microphthalmia,  myopia,  and  anterior  and/or  posterior
lenticonus.
The mutations identified in the crystallin genes analyzed
are  summarized  in  Table  1.  The  analysis  allowed  the
identification of causative nine mutations in 10 of the 60
families. Of the nine individual mutations identified, three are
novel and six have been reported previously. These include
six  missense  mutations  (CRYAA-R12C,  R21W,  R54C,
CRYAB-A171T, CRYGC-R168W, and CRYGS-S39C), two
nonsense  mutations  (CRYBB2-Q155X,  CRYGD-R140X),
and one splice mutation that was identified in two separate
families  (CRYBA1-IVS3+1G>A).  This  suggests  that
mutations in crystallin genes might account for approximately
16.6% of pediatric cataracts in the study population.
Summary  of  mutations  in  α-crystallin  genes  and  the
corresponding proteins: The α-crystallin gene family consists
of two similar genes coding for αA-crystallin (CRYAA located
on  chromosome  21q22.3)  and  αB-crystallin  (CRYAB  on
chromosome 11q22.1) sharing 57% sequence identity [39].
The first exon of each gene encodes 60 amino acids consisting
of a repeated 30 amino acid motif while the second and third
exons code for regions homologous to the small heat shock
proteins [39,40].
Description of mutations in CRYAA, their inheritance
and associated phenotypes: In the present study, mutation
analysis of CRYAA revealed three missense mutations, c.104
C>T (R12C) in family CCW46, c.130 C>T (R21W) in family
CCW36, and c.230 C>T (R54C) in family CCW55 (Figure
1A-C). It is interesting to note that the affected members of
these three families developed bilateral congenital nuclear
cataract in association with microcornea except for family
CCW36  (R21W)  where  the  affected  members  were  also
diagnosed  with  microphthalmia.  All  three  mutations
identified in this study occur outside the small heat shock
protein core domain (sHSP), and the arginines at positions 12,
21, and 54 are highly conserved among α-crystallin (Figure
2). Previous studies on the predicted topology of CRYAA
suggest that the NH2-terminal region is involved in quaternary
subunit  interactions  [41],  raising  the  possibility  that
inappropriate disulfide bridge formation by the cysteine in the
R12C and R54C mutations might lead to insolubility of the
protein. Another possibility is that αA-crystallin has been
shown to have a strong tendency to maintain a constant net
charge through evolution [42]. The mutations identified in this
study  result  in  the  replacement  of  the  basic  amino  acid,
arginine, by a neutral one, which also could affect protein–
protein interactions.
An increasing number of CRYAA mutations have been
associated  with  cataract  formation  in  humans  and  mice,
exhibiting  both  autosomal  dominant  and  recessive
inheritance.  Interestingly,  most  of  the  mutations  in  αA-
crystallin involve arginine residues and act in a dominant
fashion  (R12C  [42],  R21W/L  [43,44],  R49C  [45],  G98R
[46],  and  R116C/H  [9,43]).  These  mutations  have  led  to
isolated cataracts or cataracts associated with microcornea,
microphthalmia, and/or iris coloboma [9,43,44]. The changes,
R12C and R21W, have previously been reported to result in
the  cataract-microcornea  syndrome  [43].  The  cataract
phenotypes of these two mutations are similar, consisting of
central, zonular opacification with varying involvement of the
anterior and posterior pole. The identical mutations identified
in this study result in nuclear cataracts with microcornea. The
CRYAA mutation, W9X, in humans and the R54H mutation in
mice have been reported to cause AR cataract [47,48]. During
the preparation of this manuscript, Khan et al. [49] reported
R54C to cause an autosomal recessive cataract where the
family members homozygous for the mutation had congenital
total  cataract  with  microcornea  and  bilateral  punctuate
cataracts  were  observed  in  heterozygous  carriers  of  the
mutation. In contrast, the R54C mutation reported in this study
is  associated  with  autosomal  dominant  congenital  nuclear
cataract (ADCC) associated with microcornea. In summary,
the CRYAA mutations identified in this study result in nuclear
cataract in association with microcornea in all three families
and associated with additional microphthalmia in one family.
Description of mutations in CRYAB, their inheritance
and associated phenotypes: A novel mutation, A171T, was
identified  in  CRYAB  in  family  CCW22  (Figure  1D),  the
proband was the only available clinically confirmed affected
family member available for this study. The proband and his
unexamined  father  revealed  a  heterozygous  c.557G>A
change.  The  proband  showed  lamellar  cataract  phenotype
with no ocular or systemic abnormalities.
αB-crystallin is widely expressed in several non-ocular
tissues including cardiac and skeletal muscles [50]. Several
mutations  in  CRYAB  have  been  described  including  one
associated  with  cataract  and  desmin  related  myopathy
(Arg120Gly)  [51]  and  in  patients  with  desmin-related
myofibrillar  myopathy  without  cataract  (464delCT  and
G151X) [52]. In 2001, the CRYAB mutation, K150fs, was
associated with isolated posterior polar cataract in an English
family [10]. P20S and D140N have also been reported to cause
isolated forms of ADCC [53], but it is not clear why some
mutations in CRYAB cause muscle system disorders and/or
cardiovascular  defects  and  other  mutation  causes  isolated
cataract.
The A171T mutation identified in this study could not be
confirmed to cosegregate with cataracts due to the lack of
available family members. However, analysis of 200 normal
control chromosomes showed the absence of such a change.
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1161This mutation also lies in a phylogenetically conserved region
in the COOH-terminii of αB-crystallin (Figure 2), which is
considered  necessary  for  the  chaperone  function  of  the
protein. Most of the mutations reported in CRYAB are in this
region,  consistent  with  the  importance  of  the  sequence
encoded in exon 3 for αB-crystallin function. Further, there
have  been  reports  of  a  CRYAB  mutation  associated  with
lamellar cataract [53] similar to the phenotype observed in the
proband of family CCW22. While not definitive, all of these
suggest  that  the  A171T  mutation  is  responsible  for  the
cataracts in this patient.
Summary  of  mutations  in  β-crystallin  genes  and  the
corresponding proteins: The β-crystallins are divided into
seven subgroups, three basic (βB1-, βB2-, and βB3-crystallin)
located on chromosome 22q11.2 and four acidic forms (βA1/
βA3-crystallin  located  on  chromosome  17q11.2,  βA2-
crystallin located on chromosome 2q33, and βA4-crystallin
located on chromosome 22q11.2). All the β-crystallin genes
except  CRYBA2  have  been  associated  with  congenital
cataracts.  Screening  β-crystallin  genes  in  this  population
revealed a splice site mutation in CRYBA1 and a nonsense
mutation in CRYBB2.
Description of mutations in CRYBA1, their inheritance
and associated phenotypes: A previously reported splice site
mutation  (IVS3+1  G>A)  was  identified  in  two  families,
CCW1 and CCW57, with an AD mode of inheritance (Figure
3A,D).  The  disease  shows  complete  penetrance,  and  the
ophthalmic records confirm the opacification of the lens was
bilateral  in  all  affected  members.  The  members  whose
medical records were available in these two families showed
the affected individuals were diagnosed with zonular lamellar
opacification. However, in family CCW1, individual IV:21
had lamellar cataract and needed to undergo surgery at two
years  of  age  while  his  father  III:20  at  33  years  old  had
floriform cataract and his visual acuity is 6/36 in the right eye
and 4/60 in the left (Figure 3B,C).
To date, there are three mutations in CRYBA1 that have
been associated with cataracts. These include a three base pair
Figure 2. Protein sequence alignments.
Protein  sequence  alignment  showing
sequence conservation of CRYAA (top
alignment),  CRYAB  (second
alignment), CRYGC (third alignment),
and CRYGD (bottom alignment) among
closely related species and members of
the α- and γ-crystallin gene families.
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1162deletion  in  exon  4  (∆G91)  that  caused  AD  congenital
pulverulent nuclear cataract in three Chinese families, a suture
sparing nuclear cataract in a Swiss family and an English
family  with  the  identical  mutation  for  which  no  clinical
description  is  available  [54-57].  A  splice  site  mutation,
IVS3+1G>C, has been associated with a pulverulent cataract
phenotype in a family from Brazil [58], and a G>A transition
at the same position has been reported to cause lamellar,
sutural cataract in an Indian family and sutural nuclear cataract
with peripheral cortical opacities in an Australian pedigree
[11,59]. The CRYBA1 mutation identified in the two families
(CCW1 and CCW57) in this study is a G>A transition at the
5′ donor splice site. The mutation was found to be associated
with a characteristic zonular lamellar cataract. The Australian
pedigree  with  the  IVS3+1G>A  mutation  included  an
individual  with  a  mild  opacity.  Similar  individuals  are
included in our family (CCW1). The cause of intra-pedigree
variability  of  cataract  phenotype  is  unknown,  although  it
could result as an effect of a modifier gene or environmental
factor.
Figure 3. Mutation analysis of β-crystallin genes. A: Pedigree and RFLP analysis of family CCW1 is shown. The dot on the upper right corner
of the symbol denotes a sample was available for the study. The mutation, IVS3+1 G>A, in CRYBA1 creates a novel NlaIII restriction site.
Wild type individuals display a 488 bp and 32 bp band while the affected individual display a 488 bp, 346 bp, 142 bp, and 32 bp cleavage
product. The latter 32 bp DNA fragment expected to be generated from the PCR product due to the presence of a common NlaIII site cannot
be visualized in the agarose gel. Lens images of individuals of family CCW-1, IV:12 aged 8 years with lamellar cataract (B) and individual
III:20 aged 33 years (C), show floriform cataract respectively. D: Pedigree and RFLP analysis of family CCW58 with IVS3+1 G>A mutation in
CRYBA1 are shown. E: Mutation analysis of CRYBB2 in pedigree CCW19 shows heterozygous C>T transition in the chromatogram that
results in Q155X. M denotes 100 bp DNA ladder, C denotes unrelated control, and UD denotes undigested PCR product.
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1163The  donor  splice  site  mutation  is  expected  to  cause
disruption of βA3- and βA1-crystallins, which differ from
each other only in the length of their 5′-terminal extensions.
The first two exons of CRYBA1 encode the NH2-terminal arm,
and  exons  3–6  encode  the  Greek  key  motifs  [60].  As
speculated  by  Kannabiran  et  al.  [11],  the  effect  of  this
mutation will result in skipping of the donor splice junction
or recruitment of a cryptic splice site that would affect the
proper formation of the Greek key motifs.
Description of mutations in CRYBB2, their inheritance
and  associated  phenotypes:  As  previously  reported,  the
nonsense mutation, Q155X (c.495C>T), in exon 6 of CRYBB2
was  identified  in  family  CCW19  (Figure  3E).  Affected
individuals  in  this  three-generation  family  have  cortical
cataracts with pulverulent opacities. All affected individuals
developed poor vision between the ages five and seven years.
The mutation (Q155X) is predicted to remove the final 51
amino acids, effectively deleting ~90% of the fourth Greek
key motif and the entire COOH-terminal arm of the protein as
demonstrated in Figure 4A. The loss of these amino acids is
predicted to remove the last three β-strands in the sequence,
resulting in an unstable molecule.
Previously, six geographically distinct families have been
reported with the same chain-termination mutation (Q155X)
in CRYBB2 [14,61-65]. Clinical descriptions of the cataract
morphologies vary widely from cerulean cataract in American
Figure 4. Molecular modeling of the effects of mutations presented in Table 1 on βγ-crystallin structures. Normal structures are shown in red
and the overlaid mutant structures are shown in blue (truncations) and blue and white (substitutions). A: The normal βB2-crystallin structure
is shown in red, and the Q155X mutation is predicted to remove the COOH-terminal 51 amino acids shown in the blue overlay. B: The normal
γD-crystallin structure is shown in red and the R140X mutation is predicted to remove the COOH-terminal 34 amino acids shown in the blue
overlay. C: The normal γC-crystallin structure in the vicinity of the R168R mutation is shown in white with positive charges shown in blue
and negative charges in red. The overlaid R168W mutant is shown in red, demonstrating the substitution of the polar arginine residue by the
apolar tryptophan and consequent displacement of D107. D: The normal γS-crystallin structure in the vicinity of the fragments of 3D structures
of mutant proteins (γC-crystallin) and S39C (γS-crystallin) mutations are shown in red. Hydrogen-bonding patterns of the mutant γC- and
γS-crystallin structures are shown by dashed lines (green).
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1164and Moroccan families [14,61] to a Coppock-like phenotype
with pulverulent opacities in a Swiss family [62], punctate
cataracts  with  cerulean  opacification  in  an  Indian  family
[63],  and  progressive  polymorphic  cataracts  ranging  from
pulverulent  to  dot,  strip,  star-like,  and  sheet  shapes  in  a
Chinese family [64]. A Chilean family exhibited variable and
disparate  phenotypes  ranging  from  pulverulent  cortical
opacities to a dense posterior star-shaped subcapsular cataract
[65]. The cataract morphology identified in this study shows
little  similarity  to  the  Swiss  and  Chilean  families.  This
mutation clearly demonstrates the phenotypic heterogeneity
of the disease.
Summary  of  mutations  in  γ-crystallin  genes  and  the
corresponding proteins: The family of γ-crystallin genes is
mainly  located  in  a  cluster  of  six  highly  related  genes
(CRYGA-CRYGF) on human chromosome 2q33–35 and the
seventh  CRYG  gene  (CRYGS)  on  human  chromosome  3.
Mutations  in  CRYGC,  CRYGD,  and  CRYGS  have  been
associated with congenital and juvenile hereditary cataracts
[16,17,66]. Molecular analysis of these genes in this study
revealed  one  previously  reported  mutation  in  CRYGC
(R168W)  and  novel  mutations  in  CRYGD  (R140X)  and
CRYGS (S39C). Results of modeling the structural changes
corresponding to these mutations are shown in Figure 4B-D.
Description of mutations in CRYGC, their inheritance
and associated phenotypes: Two affected members of family
CCW33, both having an R168W mutation, were available for
study (Figure 5A). Hospital records confirmed the cataract
was  present  at  birth.  Upon  clinical  examination,  affected
individual  II:1  displayed  a  lamellar  cataract  phenotype
(Figure 5F). R168 is highly conserved among the γ-crystallins
(Figure 2). It is a hydrophilic amino acid with a positive charge
and lies within the extended strand on the surface of the
molecule,  interacting  with  water.  In  the  R168W  mutant,
arginine is replaced by tryptophan, a hydrophobic amino acid.
Changing the solvation property of an amino acid residue on
the surface of the γ-crystallin protein is predicted to diminish
its solubility [67]. In addition, replacement of R168 with a
tryptophan residue is predicted to result in a significant change
in the conformation of residues located close to residue 168,
altering  the  hydrogen  bonding  pattern  as  demonstrated  in
Figure 4C.
To date, there are three mutations reported in CRYGC,
one  insertion  mutation  and  two  missense  mutations.  The
insertion mutation (p.C42fs) resulted in zonular, perinuclear,
or  polymorphic  cataracts  with  varying  degrees  of
opacification [68]. Of the missense mutations, T5P is reported
to cause a Coppock-like cataract that presents with a dust-like
opacity of the fetal nucleus [16] and R168W has been reported
to cause lamellar and dense nuclear cataracts in Indian and
Mexican families, respectively [69,70]. It is interesting to note
that  the  lamellar  cataract  morphology  observed  in  family
CCW33 in this study is similar to that reported by Santhiya et
al. [69] in that both are childhood lamellar cataracts. While
both these families are from southern India, a single origin
could not be confirmed.
Description of mutations in CRYGD, their inheritance
and associated phenotypes: A nonsense mutation in exon 3 of
CRYGD (c.418C>T, R140X) cosegregates with cataracts in
the  affected  members  of  family  CCW45  (Figure  5B).
Ophthalmic records of the proband confirm the opacity was
present during early infancy and mainly affected the central
zone or the fetal nucleus. All other affected members of the
family  underwent  surgery  at  an  early  age.  The  R140X
mutation is predicted to result in the loss of 34 amino acids,
resulting in only partial formation of fourth Greek key motif
and misfolding of the truncated protein. The truncated part of
the R140X mutant is shown in blue (Figure 4B). This would
presumably  be  followed  by  precipitation  of  the  protein
resulting  in  opacification  of  the  lens.  The  two  previously
reported nonsense mutations in CRYGD, Y134X in Danish
families [42] and W157X reported in an Indian family [69],
also occur in exon 3, affecting the fourth Greek key motif and
causing nuclear cataract. The R140X mutation identified in
this study results in a similar nuclear cataract phenotype.
Description of mutations in CRYGS, their inheritance
and associated phenotypes: A novel missense mutation (c.
168C>G, S39C) was identified in exon 2 of CRYGS in the two-
generation family CCW47 (Figure 5C). Affected individuals
in  this  family  show  a  progressive  juvenile  onset  cataract.
Deterioration of vision of affected family members began at
seven  years  of  age.  Initially,  one  eye  had  more  severe
opacification  than  the  other.  The  sequence  variation,  c.
168C>G, in CRYGS cosegregates with the trait in the kindred
studied and is absent in 200 ethnically matched normal control
chromosomes  (Figure  5D).  Serine  is  highly  conserved  at
position 39 (Figure 2). Replacement of serine at position 39
by cysteine as shown in Figure 4D is predicted to break three
hydrogen  bonds  including  the  one  involving  S39  directly
(shown  in  white).  Although  both  serine  and  cysteine  are
neutral hydrophilic amino acids, it is possible that the new
cysteine  residue  might  form  inappropriate  homocysteine
bonds in an oxidizing environment.
This is the second report of a CRYGS mutation to be
associated  with  cataract.  In  the  previous  report,  a  G18V
mutation was identified in a Chinese family affected with
progressive polymorphic cortical cataract. The opacities in
this Chinese family varied not only between family members
but  also  between  eyes  in  the  same  patient  [17].  Similar
findings  were  observed  in  family  CCW47  in  which  the
severity of the cataracts varied from one eye to another of the
same patient. Individual V:3 shows sutural opacities in the left
eye while the right eye showed no opacification (Figure 5E).
Individual V:1 and V:2 had lamellar opacities and underwent
surgery at the end of the first decade of their lives. Phenotypic
variation in the size and density of the opacities and in their
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1165position  was  also  observed  among  other  affected  family
members.
In summary, this study identified mutations in 10 of 60
families from southern India affected by pediatric cataracts.
CRYAA was the gene most commonly involved with causative
mutations identified in 5% of the families while both CRYAA
and CRYAB together accounted for 6.6% of pediatric cataracts
in the families studied. Identical mutations were identified in
CRYBA1 (IVS3+1G>A) in two large families, suggesting that
this is a common mutation site for this gene. No mutations
were detected in CRYBA4, CRYBB1, or CRYBB3. It is notable
that  all  of  the  mutations  identified  in  this  study  cause
autosomal  dominant  cataract.  Previously,  the  same  set  of
families has been screened for mutations in connexin genes
Figure 5. Mutation analysis of γ-crystallin genes. A: Family CCW-33 shows an R168W mutation in CRYGC. B: Family CCW-45 shows an
R140X mutation in CRYGD. C: Family CCW47 shows a S39C mutation in CRYGS. D: RFLP analysis of CRYGS exon 1 shows the loss of
HpyF10VI site (mutant allele-274 bp and 204 bp, wild-type allele-478 bp). E: Individual V:3 of family CCW47 shows sutural cataract. F:
Individual II:1 of family CCW33 shows lamellar cataract. M denotes 100 bp DNA ladder, and C denotes unrelated control.
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1166(GJA3 [71] and GJA8 [72]), which revealed mutations in four
families. The frequency of involvement of the 10 crystallin
genes and two connexin genes analyzed in the Indian families
is summarized in Figure 6. Taken together, these 12 genes
account for almost one-quarter of inherited cataracts in this
group of families from southern India.
In contrast, causative mutations in these 12 genes (10
crystallin and two connexin) were not identified in over 76%
of  the  families  (n=46).  While  it  is  certainly  possible  that
causative mutations occurring in these genes were missed in
some cases or would not be detected by sequencing (e.g., large
deletions or mutations in promoter or intronic splice enhancer
sequences), it seems unlikely that these would account for a
large fraction of the families without identified mutations.
Thus, the pathogenesis of the majority of cataract families in
India seems not to be accounted for mutations by the coding
exons  of  crystallins  or  connexins,  and  mutations  in  lens
crystallins and connexins appear to be underrepresented in
this  population.  A  previous  Australian  study  involving
systematic  screening  for  mutation  in  five  crystallin  genes
(CRYAA, CRYBA1, CRYBB2, CRYGC, and CRYGD) in 38
pedigrees  has  reported  only  two  mutations  (CRYBA1-
IVS3+1G>A and CRYGD-P23T). Given that studies on two
independent  populations  describe  a  low  frequency  of
crystallin mutations, perhaps the dominance of crystallins in
the literature is not a reflection of the true distribution of
cataract genes, but rather it represents the attractiveness of the
crystallins as candidate genes for screening studies. However
the possibility cannot be excluded that mutations in one of the
other reported candidate genes such as membrane intrinsic
proteins  (MIP  and  LIM2),  intermediate  filament  protein
(BFSP2), transcription factors (MAF, PITX3, and HSF4), and
glucosaminyl (N-acetyl) transferase 2, I-branching enzyme
(GCNT2) may be the major cause of hereditary cataracts in
India. Alternatively, it is possible that currently unidentified
genes  may  be  a  more  significant  cause  of  cataracts  than
previously thought. Extensive linkage analysis and screening
of additional candidate genes will assist in discrimination
between the above hypotheses.
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